Integrated Advisors Network’s ResMed RMD Stock Holding History

Integrated Advisors Network’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-890	Closed	-$204K	–	766
2024 Q4	$204K	Sell	890 -29	-3%	-$6.98K	0.01%	670
2024 Q3	$224K	Buy	+919	New	+$205K	0.01%	664

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Integrated Advisors Network's RMD Position: Q1 2025 in Review

Integrated Advisors Network sold out of ResMed (RMD) in Q1 2025, closing a stake of 890 shares — an estimated $204K sold.

Integrated Advisors Network first reported a position in RMD in Q3 2024 and held it in 2 quarters. The position peaked at $224K in Q3 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Integrated Advisors Network reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Integrated Advisors Network sold 890 ResMed shares in Q1 2025, an estimated $204K.
Integrated Advisors Network first reported a position in ResMed in Q3 2024 and held it in 2 quarters.
Integrated Advisors Network's ResMed position peaked at $224K in Q3 2024.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Integrated Advisors Network's 13F filing for Q1 2025, filed 15 Apr 2025.